论文部分内容阅读
Background Magnetic resonance (MR) molecular imaging can detect abnormalities associated with disease at the level of cell and molecule.The epidermal growth factor receptor (EGFR) plays an important role in the development of lung cancer.This study aimed to explore new MR molecular imaging targeting of the EGFR on lung cancer cells.Methods We attached ultra-small superparamagnetic iron oxide (USPIO) particles to cetuximab (C225) anti-human IgG using the carbodiimide method.We made the molecular MR contrast agents C225-USPIO and IgG-USPIO,the latter as a control reagent,and determined concentrations according to the Fe content.Lung cancer A549 cells were cultured and immunocytochemistry (SP) was used to detect the expression of EGFR on cells.We detected the binding rate of C225-USPIO to A549 cells with immunofluorescence staining and flow cytometry.We cultured A549 cells with C225-USPIO at a Fe concentration of 50 μg/ml and assayed the binding of C225-USPIO after 1 hour with Prussian blue staining and transmission electron microscopy (TEM).We determined the effects on imaging of the contrast agent targeted to cells using a 4.7T MRi.We did scanning on the cells labeled with C225-USPIO,IgG-USPIO,and distilled water,respectively.The scanning sequences included axial T1W1,T2W1.Results Immunocytochemical detection of lung cancer A549 cells found them positive for EGFR expression.Immunofluorescence staining and flow cytometry after cultivation with different concentrations of C225-USPIO showed the binding rate higher than the control.Prussian blue staining and transmission electron microscopy revealed that in the C225-USPIO contrast agent group of cells the particle content of Fe in cytoplasmic vesicles or on surface was more than that in the control group.The 4.7T MR imaging (MRI) scan revealed the T2WI signal in the C225-USPIO group of cells decreased significantly more than in unlabeled cells,but there was no significant difference between the time gradients.Conclusions We successfully constructed the molecular imaging agent C225-USPIO targeting the EGFR ofA549 lung cancer cells.The imaging agent showed good targeting effect and specificity,and reduced MRI T2 value significantly,thus such molecular contrast agents could provide a new way to measure EGFR levels.